Biem Pharmaceuticals was founded in 1990 with headquarters in Ankara. It is a privately held pharmaceutical company engaged in manufacturing, distribution and marketing of pharmaceutical and healthcare products.
The company offers a high value pharmaceutical products portfolio on the Turkish and global market, at the same time pursuing partnerships with international leading pharmaceutical companies interested to enter on the Turkish domestic pharmaceutical market.
"Our success is an outcome of strategic focus on the pharmaceutical industry, constantly investing and promoting growth and innovation. Over the years, Biem Pharmaceuticals has extended its footprint beyond Turkey and other countries across the globe.
Our expertise lies in manufacturing and licensing of pharmaceutical products, Biem being well positioned to efficiently license, register and commercialize pharmaceutical products in Turkey, and abroad through its international partners," claims Biem.
The company’s main focus lies within the research and development of differentiated products in a wide range of therapeutic areas: oncology, hematology, radiology, transplantology, ophthalmology and gynecology.
LATEST issue 4/2022
Hannover Messe 2023’s lead theme ‘Industrial Transformation – Making the Difference’ will show the difference that exhibiting companies can make, which changes they can carry out and which innovations they can develop on the road to a climate-neutral industry. Learn more about the upcoming event from the latest issue 4/2022...
Romania’s Star Assembly, a fully-owned subsidiary of Mercedes-Benz, announced it will invest a nine-figure sum to extend its production portfolio and include the assembly of electric drive units for new generation Mercedes-EQ electric vehicles starting 2025...
Magna is expanding its footprint in Eastern Europe with the opening of a new facility in Struga, North Macedonia. Тhe new plant will support several European automakers. More details read in the latest issue 4/2022...